(Total Views: 307)
Posted On: 06/03/2019 9:35:58 AM
Post# of 36509
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
"Generex continues to make progress toward the planned spin-out of NuGenerex Immuno-Oncology (NGIO) and is in discussions with two potential partners with novel, exciting immuno-oncology platforms and clinical stage product development programs. Mr. Moscato will provide details outlining the company’s strategic plan and timing for the NGIO spin-out."
Sounds exciting.
Sounds exciting.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)